EMA Authorised: Temozolomide Teva (temozolomide) — Teva B.V.

View source ↗

Summary

EU marketing authorization granted for Temozolomide Teva (temozolomide) for glioma.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioma

Drugs mentioned

• Temozolomide Teva (temozolomide)

Snippet

Status: Authorised. Therapeutic area: Glioma. MAH: Teva B.V.. Decision date: 07/03/2024